SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-15-018860
Filing Date
2015-03-27
Accepted
2015-03-27 13:05:16
Documents
13
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K v404480_10k.htm 10-K 716104
2 EXHIBIT 21.1 v404480_ex21-1.htm EX-21.1 4375
3 EXHIBIT 23.1 v404480_ex23-1.htm EX-23.1 3171
4 EXHIBIT 31.1 v404480_ex31-1.htm EX-31.1 10538
5 EXHIBIT 31.2 v404480_ex31-2.htm EX-31.2 10737
6 EXHIBIT 32.1 v404480_ex32-1.htm EX-32.1 5090
7 EXHIBIT 32.2 v404480_ex32-2.htm EX-32.2 4879
  Complete submission text file 0001144204-15-018860.txt   7912059

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT prph-20141231.xml EX-101.INS 1279240
9 XBRL TAXONOMY EXTENSION SCHEMA prph-20141231.xsd EX-101.SCH 54706
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prph-20141231_cal.xml EX-101.CAL 49125
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prph-20141231_def.xml EX-101.DEF 286661
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE prph-20141231_lab.xml EX-101.LAB 401662
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prph-20141231_pre.xml EX-101.PRE 343011
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21617 | Film No.: 15730040
SIC: 2834 Pharmaceutical Preparations